From: Paul Bleicher [paul.bleicher@phaseforward.com]
Sent: Friday, November 02, 2001 4:32 PM
To: 'fdadockets@oc.fda.gov'
Subject: Docket Submission

To the Manager of FDA Docket Submissions:

Please accept these comments to the FDA Docket, 00D-1541, Electronic Signatures - Audit Trails.  You may cross reference these to any other Electronic Record/Electronic Signature Docket to which they apply.

I am submitting these as a MS Word 2000 file.  Please let me know if you require a different format.

Sincerely,
Paul Bleicher, MD PhD
Chairman and Chief Scientific Officer 
Phase Forward Incorporated
1440 Main Street
Waltham, Massachusetts 02451 
Voice: 781 902-4302
Fax: 781 890-4848
Email: paul.bleicher@phaseforward.com